GI Windows key facts
- Developer of anastomotic technology designed to help in tissue fusion.
- GI Windows’s last known valuation is $130.0M.
- It has raised $82.5M; the latest was Later Stage VC ($37.0M) in Oct 2024.
- Notable investors include Johnson & Johnson JJDC, Sonder Capital Management, Frederic Moll, GT Healthcare Capital Partners, JC Investco — 7 tracked in total.
- Status: Privately Held (backing).
- ·Watch GI Windows: the Monday email on marks, rounds and moves
GI Windows funding rounds
No funding rounds for GI Windows are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
GI Windows valuation
GI Windows's last known valuation is $130 million. The figure stands until a priced round, a secondary trade or an institutional fund mark prices the stock again.
GI Windows investors
7 investors are on record for GI Windows, including Johnson & Johnson JJDC, Sonder Capital Management, Frederic Moll and GT Healthcare Capital Partners.
About GI Windows
Developer of anastomotic technology designed to help in tissue fusion. The company's technology offers less invasive surgery compared to traditional staplers and offers an intervention to help in curing obesity and type two diabetes, enabling healthcare providers to treat metabolic disorders on an outpatient basis and with no surgical incisions.
- Sector
- Healthcare
- HQ
- Westwood, MA, United States
- Founded
- 2012
- Employees
- 28
- Website
- giwindows.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.
GI Windows’s last known valuation. A PrivateMarketView mark is published once fund marks, secondary prints or a priced round let us confirm it.